Colgate Palmolive India appoints Kenvue exec as MD and CEO

Kimberly-Clark (KMB) received approval from New Zealand’s Commerce Commission to acquire Kenvue, contingent on divesting Kenvue’s feminine hygiene business in NZ and Australia. The regulator cited competition concerns, requiring the sale to an approved buyer to maintain market competition. The deal is part of Kimberly-Clark’s global acquisition of Kenvue.

Kimberly-Clark's acquisition of Kenvue has been approved by New Zealand's antitrust regulator, subject to certain conditions. The deal is part of a global merger agreement between the two companies.

Colgate-Palmolive India has appointed Manish Anandani as its next CEO, effective September 28, 2026. Anandani, currently at Kenvue, will replace Prabha Narasimhan, who is moving to a regional marketing role. The company's shares are down 19% year-over-year, underperforming the Nifty 50 index.

Manish Anandani will become MD & CEO of Colgate-Palmolive India on September 28, 2026, succeeding Prabha Narasimhan. He previously worked at Colgate for 13 years and later at Johnson & Johnson and Kenvue. Colgate aims to grow through premiumization and digital commerce, with Anandani's experience aligning with these strategies.

Colgate-Palmolive India appointed a former Kenvue executive as CEO, who previously worked at Colgate-Palmolive for nearly 13 years. The outgoing CEO will take a regional marketing role. During her tenure, the stock outperformed the Nifty FMCG index, but shares fell 1% after the announcement. The company's e-commerce sales are over 50% premium products, which can impact pricing and costs.

Kenvue will sell its feminine care business in Brazil to Essity for $284 million. The deal is part of Kenvue's strategic review of its portfolio. Essity, a Swedish hygiene and health company, will expand its presence in the Brazilian market. Kenvue's stock has risen 10.75% year-to-date.